Contact us
Whether you're interested in partnering with us, learning more about our lead compound AUS_001, or investing to accelerate its delivery, please contact us. We would welcome the opportunity to discuss further with potential partners.
Find us
Terra Australis Pharmaceuticals PTY LTD is our operating and research affiliate headquartered in Adelaide, South Australia.
info@australispharma.com
4596 Ish Drive Unit 230
Simi Valley
CA 93063
Monday - Friday
9:00am - 6:00pm (Pacific Time)
Frequently asked questions
We have successfully raised $30M over the last 10+ years and, as of 2025, have no third-party debt on the balance sheet. We have enough cash on hand to proceed through at least Phase 1.
Please email us directly for more information (subject to an NDA).
In 2025, we received the exciting news that we’ve received for AUS_001, both Orphan Drug Designation for malignant gliomas and Rare Pediatric Disease Designation for treating pediatric-type diffuse high-grade gliomas!
Our objective is to raise $10M-$50M in capital to launch additional human trials beyond Phase 1 in more cancers, particularly childhood cancers. For more information, please visit our Investors page.
We have had very strong academic collaborations as noted in our published posters. Please contact us directly for a comprehensive list.
Join us on this important journey to find new therapies for patients with cancer
We are seeking investors and partners to join us in this mission. For more information, details on ongoing studies, and next steps, please reach out to us.